Selank purity and testing: what buyers actually need to check

Last updated 2026-07-26

What does "purity" even mean for a peptide like selank?

Purity, in this context, means the percentage of the material in the vial that is actually the intended peptide (selank, a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro) rather than leftover synthesis byproducts, truncated sequences, deletion peptides, trifluoroacetic acid (TFA) salts, or plain filler. A vial can look identical to another and differ wildly in what's actually in it. Most peptide sellers report purity as a single number from high-performance liquid chromatography (HPLC), like "98.2% pure." That number describes how much of the detected material matches the expected peak retention time and area, essentially how clean the chromatogram is. It does not, by itself, prove the peak is selank. That's a separate question, answered by mass spectrometry (mass spec), which confirms the molecular weight matches selank's expected mass (roughly 751 Da for the free peptide, as listed in its PubChem compound record) ^[1]. So a full purity claim really needs two things: an HPLC trace showing a clean, single dominant peak, and a mass spec result confirming that peak's identity. A COA with only one of these is half a picture. A COA with neither, just a stated percentage and no chromatogram, is not verifiable at all. There is no FDA monograph or USP standard specifically governing selank purity, because selank has never been approved as a drug in the United States. It's sold in the US peptide market almost universally under "research use only" labeling, meaning the seller is not representing it as intended for human consumption. That labeling matters legally and practically, and it's worth reading selank side effects alongside this if you're thinking about actually using it, since dosing and adverse effect data are also thin outside Russian sources.

Is selank FDA approved, and does Russian approval mean anything here?

No. Selank is not approved by the FDA for any use in the United States. Searching the agency's own Drugs@FDA database, which lists every approved new drug application, turns up no record for selank under any name ^[2]. Any US seller marketing it for anxiety or cognition without RUO framing is doing so outside FDA's approved-drug pathway. Selank does have a history in Russia, where it was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences and has been studied and, by some accounts, registered for clinical use there as an anxiolytic. That's a real regulatory history in a different country under a different system, not the same evidentiary bar the FDA applies. Russian drug registration does not require the same phase III trial infrastructure, independent replication expectations, or public trial registry transparency that FDA approval does. This is the single most important thing to understand before buying: selank's clinical literature is largely Russian-language, published in Russian pharmacology and neuroscience journals, and has not been replicated in Western, peer-reviewed, English-language randomized controlled trials. That doesn't mean the Russian work is worthless. A pharmacokinetic study of selank published in Bulletin of Experimental Biology and Medicine describes its absorption and stability profile in animal models using standard analytical methods ^[3], and that kind of chemistry-and-pharmacokinetics work is more methodologically checkable than the broader efficacy claims. But nobody in the US or EU has independently reproduced the human anxiolytic effect claims under modern trial standards, and there's no FDA safety or efficacy determination to point to. Treat the purity question and the efficacy question as separate: even a perfectly pure vial of selank is a substance with thin, non-replicated human data behind it. For the full picture on what that literature actually says, see selank.

What should a real certificate of analysis (COA) actually show?

A usable COA is batch-specific, dated, and traceable to the actual vial you're holding, not a stock PDF that could belong to any batch the seller has ever sold. Look for a lot number or batch number printed on the COA that matches a number printed on your product label. If those don't match, or if there's no batch identifier on either, the COA proves nothing about what's in your hands. A COA worth trusting includes: - The testing lab's name and, ideally, that it's a third party independent of the seller.

• HPLC purity as a percentage, with the actual chromatogram image (more than the number).
• Mass spectrometry data confirming molecular weight against selank's expected mass.
• The batch/lot number matching your product.
• A test date recent relative to your purchase. What a COA does not need to have, and what should raise your eyebrows if it's the only thing offered: a purity number with no chromatogram, no lab name, or a lab name you can't find any independent trace of online. Peptide forums and buyer communities have flagged sellers reusing a single "98.5% pure" COA image across multiple product listings for years; that's a red flag pattern worth knowing, even though it's anecdotal and not something a government body tracks.

HPLC vs mass spec: what's the difference and why do you need both?

HPLC (high-performance liquid chromatography) separates the components of a sample by how they move through a column, then measures how much material comes off at each retention time. It's excellent at telling you how clean a sample is: a single sharp peak suggests few contaminants; a messy trace with multiple peaks suggests degradation products, incomplete synthesis, or byproducts. What HPLC alone can't tell you is what that peak actually is. Two different peptides can have similar retention times under certain column conditions. Mass spectrometry measures the mass-to-charge ratio of ionized molecules, which lets a lab confirm the molecular weight of whatever's in the sample. For selank, PubChem's compound record lists a molecular weight close to 751.4 Da for the peptide free base ^[1] (some COAs report it as the acetate or TFA salt form, which shifts the number slightly). If the mass spec result doesn't land near that figure, you don't have selank, regardless of what the HPLC purity number says. So the honest short answer to "do I need both" is yes. HPLC without mass spec confirms cleanliness but not identity. Mass spec without HPLC confirms identity but says nothing about how much contaminant is riding along. A COA reporting both, ideally from the same batch and same testing date, is the closest a buyer gets to real assurance without paying for their own independent lab test.

Can I get a peptide independently tested myself?

Yes, and some serious buyers do. Independent third-party peptide testing services exist that accept a small sample and run HPLC and mass spec for a fee, typically somewhere in the range of $40 to $150 per sample depending on the lab and turnaround time, though exact pricing varies by provider and isn't standardized or government-set. This is the only way to get purity data you didn't have to trust the seller to provide. The catch: it costs money and time on top of what you already paid for the product, and a single sample test tells you about that one vial, not necessarily every batch a seller ships. If you're buying repeatedly from the same source, independent testing on a periodic basis (say, once every few batches) is more useful than a one-off test, since it can catch a seller who cuts quality over time. For most buyers this isn't practical for every purchase. It's more realistic as a spot-check tool, or as something you do once with a new supplier before committing to buying from them regularly.

What purity percentage should I actually look for?

Reputable peptide sellers in the research space commonly advertise 98% or higher HPLC purity, and that's a reasonable floor to look for, though it's an industry norm rather than a legal requirement, since there's no regulatory minimum for RUO-labeled research peptides in the US. Below roughly 95%, you're looking at a meaningfully higher proportion of byproduct material, which for injectable or nasal-use peptides matters more than it would for something you're not putting in your body. Here's a rough way to think about what different purity bands typically mean in the peptide synthesis world: | Purity range | What it typically indicates |

What actually gets counted as "impurity" in a peptide sample?

Impurities in synthetic peptides generally fall into a few categories, and knowing them helps you read a COA more critically. Truncated sequences happen when the peptide chain doesn't finish building during solid-phase synthesis, leaving a shorter fragment. Deletion sequences are similar: a piece missing from the middle. Racemization can flip the chirality of an amino acid, changing how the peptide behaves. Residual solvents and coupling reagents from the synthesis process, TFA salts left over from cleavage and purification, and moisture content also count. A COA that only reports "purity" as one number is bundling all of this into a single figure derived from the HPLC peak area. That's standard practice in the industry, but it means a stated 98% doesn't tell you which of these specific impurity types make up the other 2%. For most buyers this level of detail isn't necessary, but if you're seeing any adverse reaction pattern that doesn't match what's described in selank side effects, impurity profile is one of the first things worth questioning, since a bad batch is a more plausible explanation than a systemic drug effect that wasn't seen in the underlying studies.

How do I tell selank apart from semax on a label or COA, and does it matter for purity?

Selank and semax are different peptides from the same Russian research lineage, and they get confused constantly, including on product labels and even in some COAs where a template wasn't updated correctly. Semax is an ACTH(4-10) analog, structurally and functionally distinct from selank, which is a Tuftsin analog. They have different molecular weights, different expected mass spec results, and different amino acid sequences entirely. If you're checking a COA, the molecular weight is the fastest tell: selank's expected mass sits close to 751 Da, while semax's PubChem record lists a distinct molecular weight around 813 Da for its own sequence ^[4]. If a COA lists a mass that doesn't match the product it's supposedly for, either the wrong COA got attached to the wrong listing, or something more concerning happened during production. Either way, that's a red flag, not a paperwork technicality to shrug off. Beyond the purity-testing angle, these two peptides also differ in their claimed effects and evidence base, and conflating them leads to bad expectations. If you're trying to decide which one is more relevant to what you're after, semax vs selank and selank vs semax both cover the comparison directly.

What red flags suggest a seller is cutting corners on testing?

A few patterns show up repeatedly in peptide buyer communities and are worth watching for, even though none of them are things a government inspector is checking on your behalf. No batch numbers anywhere, on the product or the COA, so there's no way to link the two. A COA that's clearly a stock image or PDF used across a seller's entire catalog rather than tied to one production run. Purity numbers with no chromatogram or mass spec data at all, just a stated percentage. Testing labs that don't show up anywhere else online, have no verifiable address, or whose name a quick search turns up nothing on. Prices dramatically below the rest of the market for the same stated purity, which is a classic signal that corners are being cut somewhere, whether in synthesis, testing, or storage. On the flip side, sellers who post dated, batch-matched COAs with visible chromatograms, name their testing lab, and are consistent about it across their catalog are doing the bare minimum of what a serious buyer should expect. That's not proof of clinical efficacy, and it says nothing about whether the Russian anxiolytic data will hold up in a Western trial that hasn't been run. It just means what's in the vial is more likely to be what the label says.

Does third-party testing prove selank works, or just that it's clean?

Just that it's clean, or at least that it's what it claims to be at a given purity. This distinction trips people up constantly, and it's worth being blunt about it: a spotless COA says absolutely nothing about whether selank does what Russian studies suggest it might do for anxiety or cognitive performance in humans. The efficacy question and the purity question are answered by completely different kinds of evidence. Purity is answered by chemistry: HPLC, mass spec, a lab bench. Efficacy is answered by clinical trials: randomized, controlled, ideally double-blind, ideally replicated by researchers with no stake in the outcome. Selank has real chemistry data behind its purity claims when sellers bother to provide it. Its efficacy data, by contrast, sits almost entirely in Russian-language publications that haven't been replicated in Western peer-reviewed trials, a gap that matters regardless of how clean any given vial tests. So don't let a good COA talk you into more confidence about outcomes than the underlying science supports. A 99% pure vial of a substance with thin human trial data is still a substance with thin human trial data. It's just not also contaminated.

Where should I actually buy if purity documentation matters to me?

Look for sellers who publish batch-matched COAs with visible HPLC chromatograms and mass spec confirmation, name their testing lab, and are consistent about doing this across their whole catalog rather than for one flagship product. That's the practical version of due diligence most buyers can actually do without paying for their own lab test. Selank Co reviews providers along these lines and points readers toward the provider-reviewed fulfillment route rather than compounding or manufacturing anything itself; the actual product is dispensed through a pharmacy partner, and the documentation trail matters more than marketing copy on a landing page. If you're at the point of actually comparing sources, buy selank covers what to check before you order, and selank dosage is worth reading alongside it since dosing conventions in the (largely Russian) literature don't map cleanly onto US research-chemical dosing practices.

What's the honest bottom line on selank purity and testing?

There's no FDA purity standard for selank, because it isn't an FDA-approved drug in the US; it circulates as a research-use-only compound. The closest thing to assurance a buyer can get is a batch-matched, dated COA showing both HPLC purity (98%+ is a reasonable target, not a legal requirement) and mass spec identity confirmation near selank's expected 751 Da mass. Good documentation tells you what's probably in the vial. It tells you nothing about whether the Russian clinical literature on selank's anxiolytic and nootropic effects, real as that literature is, would hold up under the kind of Western, replicated, randomized trial scrutiny that FDA approval requires and that selank has never gone through. Keep those two questions separate, ask for the paperwork, and don't mistake a clean chromatogram for a green light on efficacy.

Frequently asked questions

Is selank legal to buy in the United States?

Selank isn't a scheduled controlled substance in the US, so it's generally sold as a "research use only" product rather than as an approved drug or supplement for human use. It has no FDA approval for any indication. Buyers should understand RUO labeling as a real legal distinction, not marketing language, and treat the product accordingly.

What does a selank COA need to show to be trustworthy?

A trustworthy COA has a batch/lot number matching the product label, a recent test date, the testing lab's name, an HPLC chromatogram (more than a purity percentage), and mass spectrometry data confirming molecular weight near selank's expected ~751 Da mass. Missing any of the chromatogram, batch number, or mass spec data makes the document much less verifiable.

What HPLC purity percentage is considered good for selank?

98% or higher HPLC purity is a common benchmark among reputable research peptide sellers, though it's an industry convention rather than a regulated minimum. Purity below roughly 95% suggests a meaningfully higher byproduct load. There's no government-set purity threshold specifically for selank since it isn't an FDA-approved drug.

Can I independently test a peptide I bought?

Yes. Third-party peptide testing services will run HPLC and mass spec on a submitted sample, typically for somewhere around $40 to $150 depending on the lab, though pricing isn't standardized. This is the only way to verify purity without relying on the seller's own COA, but it costs extra time and money per test.

Does selank's Russian regulatory history mean it's approved like an FDA drug?

No. Selank has a registration and use history in Russia through that country's regulatory system, which is a different evidentiary bar than FDA approval. It has never gone through FDA review, has no record in the Drugs@FDA database, and its clinical literature is overwhelmingly Russian-language and hasn't been replicated in Western randomized controlled trials.

How is selank different from semax, and why do buyers confuse them?

Selank is a Tuftsin analog; semax is an ACTH(4-10) analog. They're different peptides with different molecular weights (selank near 751 Da, semax near 813 Da per PubChem), different sequences, and different claimed effects, but they come from the same Russian research tradition and are often sold by the same vendors, which leads to labeling mix-ups and conflated marketing claims.

Does a high purity percentage mean selank actually works for anxiety?

No. Purity testing (HPLC, mass spec) only confirms what's chemically in the vial and how clean it is. It says nothing about clinical efficacy. Selank's anxiolytic effect claims come from Russian studies that haven't been replicated in Western peer-reviewed human trials, regardless of how pure any given batch tests.

What's the expected molecular weight of selank, and why does it matter for testing?

Selank's expected molecular weight is close to 751 Da for the free peptide, per its PubChem compound record (COAs reporting a salt form may show a slightly different figure). Mass spectrometry results should land near this number; if they don't, the sample isn't selank regardless of what an HPLC purity percentage claims.

What are common impurities found in synthetic peptides like selank?

Typical impurities include truncated or deletion sequences from incomplete synthesis, racemized amino acids, residual synthesis solvents or coupling reagents, and leftover TFA salts from purification. A single HPLC purity percentage bundles all of these into one number without specifying which are present.

Are there red flags that suggest a seller isn't testing their selank properly?

Watch for missing batch numbers, COA PDFs reused across an entire product catalog, purity claims with no chromatogram or mass spec data, testing labs with no verifiable online presence, and prices far below market rate for the claimed purity. Any of these should lower your confidence in the stated purity.

Where can I read the actual clinical evidence behind selank before buying?

Start with a review of the primary literature rather than seller marketing copy, since most human data is Russian-language and hasn't been replicated in Western trials. A dedicated evidence review covering study quality and gaps is more useful than a purity certificate for deciding whether selank is worth trying at all.

Sources

1. National Center for Biotechnology Information (PubChem), Selank compound record: Selank's chemical structure and molecular weight identity used for mass spec confirmation
2. U.S. Food and Drug Administration, Drugs@FDA database: Selank has no FDA New Drug Application or approval record, verifiable by absence from the Drugs@FDA database
3. Kolyasnikova KN et al., "Pharmacokinetics of Selank in rat blood after intranasal administration," Bulletin of Experimental Biology and Medicine, PMID 24261121: Selank pharmacokinetic and stability data from a peer-reviewed animal study using standard analytical methods
4. National Center for Biotechnology Information (PubChem), Semax compound record: Semax's molecular weight and structure, distinct from selank, used to distinguish the two peptides on a COA
5. U.S. Food and Drug Administration, "Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only" guidance: Basis for how research-use-only labeling functions as a distinct regulatory category from an approved drug
6. Kolyasnikova KN et al., "Comparative Pharmacokinetics of Selank in Compliance with Various Ways of Administration," Bulletin of Experimental Biology and Medicine, PMID 22715561: Comparative pharmacokinetic data supporting selank's identity and behavior across administration routes